Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 659.53M P/E - EPS this Y -142.20% Ern Qtrly Grth -
Income -36.84M Forward P/E -7.95 EPS next Y -29.00% 50D Avg Chg 24.00%
Sales 56.52M PEG - EPS past 5Y - 200D Avg Chg 67.00%
Dividend N/A Price/Book 3.87 EPS next 5Y - 52W High Chg -
Recommedations 2.40 Quick Ratio 9.50 Shares Outstanding 68.60M 52W Low Chg 185.00%
Insider Own 4.65% ROA -10.10% Shares Float 47.88M Beta 0.97
Inst Own 99.47% ROE -14.67% Shares Shorted/Prior 3.89M/5.28M Price 13.75
Gross Margin -48.23% Profit Margin -65.17% Avg. Volume 216,427 Target Price 62.00
Oper. Margin -322.75% Earnings Date Aug 12 Volume 182,773 Change 3.62%
About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company's product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington. As of May 20, 2024, Alpine Immune Sciences, Inc. operates as a subsidiary of Vertex Pharmaceuticals Incorporated.

ALPN Chatroom

User Image biotechdollars Posted - 2 months ago

$ALPN I felt 65 was low for alpn. However I feel great about 65 now. The 303 data was thin. The second set of 303 patients data, released before the acquisition, were not as strong.

User Image biotechdollars Posted - 2 months ago

$ALPN we own vktx much lower, fortunately. We are picking up bcab. How about you?

User Image Aigner_Andreas Posted - 4 months ago

TF BUY $ALPN at 6.82 : 6.58 MicroCap -22% Shp 1.3 S 0 N 0 RSI 35.99% SRSI 76.64% ADXR 51.86 #stocks #trading #finance #market

User Image NVDAMillionaire Posted - 4 months ago

$ALPN Alpine Immune Sciences, Inc. (NASDAQ:ALPN): Advancing Povetacicept, a Potentially Best-in-Class Dual BAFF/APRIL Inhibitor, Across Multiple Autoimmune Indications http://beyondspx.com/2024/08/05/alpine-immune-sciences-inc-nasdaqalpn-advancing-povetacicept-a-potentially-best-in-class-dual-baff-april-inhibitor-across-multiple-autoimmune-indications/

User Image biotechdollars Posted - 06/30/24

$ALPN I'd like to communicate off stocktwits, if you have a suggestion. I was not enamored with the 303 Igan second group of 5's performance. First group of 5 stronger.

User Image tan1642 Posted - 6 months ago

$IOVA $ALPN $8.54 on 10/26/23. $64.40 on 04/11/24. It can happen.

User Image Aigner_Andreas Posted - 7 months ago

TF SELL $ALPN at 6.82 : 64.24 MicroCap 98% Shp 0.62 S 0.09 N 0.2 RSI 7.63% SRSI 0% ADXR 62.23 #stocks #trading #finance #market

User Image tradethehalt Posted - 7 months ago

$ALPN trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $64.99 Vol: 4.28M.

User Image HaltTradeAlert Posted - 7 months ago

$ALPN Halt Time: 19:50:00 Issue Symbol: ALPN Reason Code: T12 Last Price: $64.97 Market Cap: $4456779918 Volume: 4169642.0 Relative Volume: 2.34 Shares Float: 68597504 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

User Image Mergerbrief Posted - 7 months ago

$ALPN $VRTX - Tender Offer Expires MergerBrief.com

User Image CTFNLighthouse Posted - 7 months ago

$ALPN $VRTX The HSR waiting period in connection with Vertex Pharmaceuticals’ proposed acquisition of Alpine Immune Sciences expired on May 9. The tender offer will expire at one minute past 11:59pm ET on May 17, unless the offer is extended.

User Image intratio Posted - 7 months ago

$ALPN https://www.intratio.com/stock-forecast/ALPN The predictive algorithm is predicting the value of this company will soon begin to trend sharply downward and will continue to have a very poor trend over the next months

User Image epsguid Posted - 7 months ago

$ALPN reported a loss of $0.28, consensus was ($0.43) via @eWhispers #epsbeat http://eps.sh/d/alpn

User Image Stock_Titan Posted - 7 months ago

$ALPN $VRTX Alpine Immune Sciences Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/ALPN/alpine-immune-sciences-reports-first-quarter-2024-financial-vo4a5lekydep.html

User Image intratio Posted - 7 months ago

$ALPN https://www.intratio.com/stock-forecast/ALPN Our algorithm has detected that this stock s value has a rather grim outlook for the immediate future and predicts a gravely bleak future

User Image ScottieJay541 Posted - 7 months ago

$ALPN Earnings is going to take this to 70+

User Image intratio Posted - 7 months ago

$ALPN Our trained model judges that this stock s price has an extremely bleak prognosis for the near future and will continue to have a very poor trend over the next months

User Image intratio Posted - 7 months ago

$ALPN https://www.intratio.com/stock-forecast/ALPN The trained A.I assessed this stock s value will drop in the coming days and will continue to trend quite negatively in the next months

User Image intratio Posted - 7 months ago

https://www.intratio.com/stock-forecast/ALPN The algorithm computed that the value of this equity has an extremely bleak prognosis for the near future and has really poor long-term fundamentals $ALPN

User Image ParadiseSaudiArabia Posted - 7 months ago

$ALPN

User Image intratio Posted - 7 months ago

https://www.intratio.com/stock-forecast/ALPN ALPINE IMMUNE SCIENCES, INC. The automated equity analyst foresees that the price of this stock will soon begin to trend sharply downward with a very negative long-term outlook $ALPN

User Image StockednLoaded Posted - 7 months ago

$IOVA- Price Discovery doesn't start until $27/share Buyout offers don't get looked at until they contain ten 0's. $XBI $DCPH $ALPN AMBRX CBAY $FUSN

User Image Aigner_Andreas Posted - 04/30/24

#TrendFollowing #TOP10 WK 18 BUY US $VST $NRG $ALPN $BSX $APH ETN RSG WAB SFM AXP

User Image NinjaXLightning Posted - 04/24/24

$HCP For recent reference, $ALPN accepted a $65 per share cash buyout from $VRTX a couple of weeks ago and has been trading at about $64.50 per share. Should see this trading over $34.

User Image Aigner_Andreas Posted - 04/23/24

#TrendFollowing #TOP10 WK 17 BUY US $VST $AYX $NRG $ALPN $CAT RSG SLM WAB AXP SFM

User Image intratio Posted - 7 months ago

$ALPN https://www.intratio.com/stock-forecast/ALPN The predictive algorithm is predicting that this stock s price will quickly deteriorate in the near future and has a dramatic negative long-term outlook

User Image hospitalphysician Posted - 8 months ago

@biotechdollars Personally, I feel a little ripped off on $ALPN. The price was a little low. Are you looking at anything else right now?. It is a tough market. I’m 80% cash, 10% long (9% is in one company) , and 10% short

User Image krayzk4 Posted - 8 months ago

$ALPN if market has a big correction does this fall with it?

User Image Aigner_Andreas Posted - 8 months ago

#TrendFollowing #TOP10 WK 16 BUY US $VST $EME $ALPN $NRG $WAB HIG SPOT TRV CAT THC

User Image RonIsWrong Posted - 8 months ago

$ALPN $XBI $MRUS $SWTX $FUSN FUSN ☑️ ALPN ☑️ SNDX _?_ SWTX - bring it !! KRYS _?_

Analyst Ratings
Wedbush Neutral May 16, 24
TD Cowen Hold Apr 16, 24
Leerink Partners Market Perform Apr 12, 24
Wedbush Neutral Apr 11, 24
Wolfe Research Peer Perform Apr 11, 24
RBC Capital Sector Perform Apr 11, 24
Morgan Stanley Equal-Weight Apr 11, 24
Guggenheim Buy Apr 9, 24
HC Wainwright & Co. Buy Mar 21, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rickey James Paul See Remarks See Remarks Jan 25 Sell 23.1 118,000 2,725,800 01/29/24
Rickey James Paul See Remarks See Remarks Jan 25 Option 8.11 118,000 956,980 44,000 01/29/24
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 28 Sell 20.04 1,016 20,361 12/29/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 28 Option 6.7 75,457 505,562 2,675,421 12/29/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 22 Sell 20.23 91,884 1,858,813 12/27/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 22 Option 0.55 91,884 50,536 29,573 12/27/23
Rickey James Paul See Remarks See Remarks Dec 19 Sell 19.21 15,213 292,242 12/21/23
Rickey James Paul See Remarks See Remarks Dec 19 Option 5.02 15,213 76,369 15,213 12/21/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 19 Sell 20.01 2,402 48,064 12/21/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 19 Option 0.45 2,402 1,081 2,402 12/21/23
Rickey James Paul See Remarks See Remarks Dec 14 Option 5.02 58,787 295,111 1,800 12/18/23
Rickey James Paul See Remarks See Remarks Dec 14 Sell 19.03 58,787 1,118,717 12/18/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 08 Sell 17.24 118,000 2,034,320 12/12/23
GOLD MITCHELL Executive Chairman a.. Executive Chairman and CEO Dec 08 Option 0.45 8,613 3,876 8,613 12/12/23
Rickey James Paul See Remarks See Remarks Dec 04 Sell 16.05 70,811 1,136,517 12/06/23
Rickey James Paul See Remarks See Remarks Dec 04 Option 3.23 70,811 228,720 6,446 12/06/23
Rickey James Paul See Remarks See Remarks Nov 30 Sell 16 700 11,200 12/01/23
Rickey James Paul See Remarks See Remarks Nov 30 Option 3.23 700 2,261 700 12/01/23
Rickey James Paul See Remarks See Remarks Nov 06 Sell 16.03 18,003 288,588 11/08/23
Rickey James Paul See Remarks See Remarks Nov 06 Option 3.23 10,989 35,494 18,003 11/08/23
Venkatesan Jay Director Director Jul 15 Option 0.45 20,063 9,028 238,126 07/19/22
Frazier Life Sciences VIII, L.... 10% Owner 10% Owner Feb 11 Buy 7.1006 112,665 799,989 1,484,115 02/15/22